PROCEPT BioRobotics (PRCT)2025-04-24 11:06Revenue Growth - Total revenue for Q1 2025 was 60.3 million, reflecting a growth of 50% year-over-year[4] - U.S. handpiece and consumable revenue was 8.9 million, representing a 104% increase compared to the previous year[4] - Total revenue for PROCEPT BioRobotics Corporation in Q1 2025 reached 44,539,000 in Q1 2024, representing a growth of 55.4%[26] - U.S. revenue totaled 40,201,000 in Q1 2024, marking a year-over-year increase of 50.1%[26] - Revenue from handpieces and other consumables in the U.S. rose to 23,618,000 in the previous year, reflecting a growth of 60.7%[26] - Total revenue outside of the U.S. was 4,338,000 in Q1 2024, indicating a growth of 104.1%[26] - Handpieces and other consumables revenue outside the U.S. increased to 2,343,000 in the prior year, showing a growth of 90.1%[26] - Service revenue in the U.S. grew to 2,347,000, representing a year-over-year increase of 53.2%[26] - Service revenue outside the U.S. also saw growth, reaching 255,000, which is a 111.4% increase[26] Financial Performance - Gross margin for Q1 2025 improved to 64%, compared to 56% in Q1 2024[5] - Operating expenses for Q1 2025 totaled 52.7 million in the prior year[6] - Net loss for Q1 2025 was 26.0 million in Q1 2024[7] - The company increased its full-year 2025 revenue guidance to 35.0 million, unchanged from prior guidance[12] Market Presence and Innovation - As of March 31, 2025, the company had an installed base of 547 robotic systems in the U.S.[4] - The company continues to focus on expanding its market presence and enhancing its product offerings to drive future growth[26] - PROCEPT BioRobotics Corporation is committed to ongoing research and development to innovate new products and technologies in the medical robotics field[26]